Telesis Bio(TBIO.US)

Last Updated 19:00:00 ET
longbridge loading

Biotalys Reports Full-Year 2025 Financial Results and Business Highlights

Unusual Whales·
US
BTAI
+0.93%
US
TBIO
0.00%
US
TLIS
0.00%
Unusual Whales·
US
BTAI
+0.93%
US
TBIO
0.00%
US
TLIS
0.00%

Terremoto wins $108m in Series C to drive cancer and rare disease programmes

Pharmaceutical Technology·
US
TBIO
0.00%
US
MBX
+3.42%
US
FBT
+2.14%
Pharmaceutical Technology·
US
TBIO
0.00%
US
MBX
+3.42%
US
FBT
+2.14%

Telesia Extends Timetable for 2025 Accounts and Updates 2026 Financial Calendar

Tip Ranks·
US
LABU
+11.76%
US
IBB
+2.27%
US
XBI
+3.88%
Tip Ranks·
US
LABU
+11.76%
US
IBB
+2.27%
US
XBI
+3.88%

Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026

Tip Ranks·
US
XBI
+3.88%
US
ASMB
-0.98%
US
FBT
+2.14%
Tip Ranks·
US
XBI
+3.88%
US
ASMB
-0.98%
US
FBT
+2.14%

Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy

Tip Ranks·
US
TBIO
0.00%
US
XBI
+3.88%
US
IBB
+2.27%
Tip Ranks·
US
TBIO
0.00%
US
XBI
+3.88%
US
IBB
+2.27%

Stocks in Play: Satellos Bioscience Inc.

Baystreet·
US
IBB
+2.27%
US
SBIO
+3.75%
US
ASMB
-0.98%
Baystreet·
US
IBB
+2.27%
US
SBIO
+3.75%
US
ASMB
-0.98%
© 2026 Longbridge｜Disclaimer